Gay Asian Proud free online event this Friday 18th September

Thorne Harbour Health, 16th September 2020

Gay Asian Proud (GAP) is excited to organise an online chat, Questioning Stereotypes And Assumptions, this Friday, 18 September, 6.00 PM – 8.00 PM pm AEST (5.30 PM  – 7.30 PM SA time). 

We welcome all GAP members, and Asian same-sex attracted men (cis and transgender).

If you are not a GAP member yet, please email gap@thorneharbour.org to be placed on our mailing list. We will invite you to upcoming events.

We want to hear your experience with stereotypes about Asian gay and bisexual men, the assumptions we make based on our cultural upbringing, our inherent bias, and how we could address them in a respectful way that facilitates intercultural understanding. This is your platform. We want to hear you talk.

Facilitated by James & Amirul, Coordinators of Gay Asian Proud (GAP), a social support group for Asian gay & bisexual men (cis and transgender).

Sign up now at Eventbrite to claim your FREE ticket! We can’t wait to see you this Friday! 

 

Disparities in characteristics in accessing public Australian sexual health services between Medicare‐eligible and Medicare‐ineligible MSM

Disparities in characteristics in accessing public Australian sexual health services between Medicare‐eligible and Medicare‐ineligible men who have sex with men

Australian and New Zealand Journal of Public Health

Anysha M. Walia, Christopher K. Fairley, Catriona S. Bradshaw, Marcus Y. Chen, Eric P.F. Chow

First published: 31 August 2020
https://doi.org/10.1111/1753-6405.13029
Abstract:

Objectives: Accessible health services are a key element of effective human immunodeficiency virus (HIV) and sexually transmitted infection (STI) control. This study aimed to examine whether there were any differences in accessing sexual health services between Medicare‐eligible and Medicare‐ineligible men who have sex with men (MSM) in Melbourne, Australia.

Methods: We conducted a retrospective, cross‐sectional study of MSM attending Melbourne Sexual Health Centre between 2016 and 2019. Demographic characteristics, sexual practices, HIV testing practices and STI diagnoses were compared between Medicare‐eligible and Medicare‐ineligible MSM.

Results: We included 5,085 Medicare‐eligible and 2,786 Medicare‐ineligible MSM. Condomless anal sex in the past 12 months was more common in Medicare‐eligible compared to Medicare‐ineligible MSM (74.4% vs. 64.9%; p<0.001) although the number of partners did not differ between groups. There was no difference in prior HIV testing practices between Medicare‐eligible and Medicare‐ineligible MSM (76.1% vs. 77.7%; p=0.122). Medicare‐ineligible MSM were more likely to have anorectal chlamydia compared to Medicare‐eligible MSM (10.6% vs. 8.5%; p=0.004).

Conclusions: Medicare‐ineligible MSM have less condomless sex but a higher rate of anorectal chlamydia, suggesting they might have limited access to STI testing or may be less willing to disclose high‐risk behaviour.

Implications for public health: Scaling up access to HIV and STI testings for Medicare‐ineligible MSM is essential.

Flux Study COVID-19 Diary Recruitment and Report

Kirby Institute, UNSW, July 2020

Social distancing restrictions due to COVID-19 may affect how gay and bisexual men are arranging their sex lives and taking care of their health. And this will likely also affect trends in HIV infection and STIs over coming months, or even years. Monitoring the impact of COVID-19, before, during, and after the pandemic, is essential to understanding and responding to trends in HIV infection, mental health, and STIs.

​This study investigating the lived experiences of COVID-19 among gay and bisexual men including isolation, support, mental health and resilience, income loss, and access to health services. We will address how gay and bisexual men experience, engage with, and emerge from, COVID-19.

What does participation in this research require? 

If you decide to take part in this study, we will ask you to do the following:

  1. Your first questionnaire: This questionnaire collects information about you and your previous experiences.

  2. Weekly diary: After completing the your first survey, you will be asked to complete a 5-minute diary each Sunday.

What’s in it for you? 

We value our participants! To show our appreciation, for every survey you complete, you’ll automatically go in a raffle to win prizes in the form of gift cards to the value of $200.

Links

Stigma towards people who inject drugs and sex workers prevalent, according to new Australian study

Centre for Social Research in Health, UNSW, July 2020

Priority groups at risk of blood borne viruses and sexually transmissible infections are still likely to experience negative behaviour from the general public and in healthcare settings according to a recent report from the Stigma Indicators Monitoring Project.

86% of the general public sampled self-reported that they would behave negatively towards people who inject drugs to some extent, as did 56% of healthcare workers and 55% of healthcare students. Additionally, 64% of the general public, and 36% and 31% of healthcare workers and students respectively, self-reported likely negative behaviour (to some extent) towards sex workers.

 

 

Diagnosis and Management of Syphilis in Patients With HIV Co-infection

Khaw, C., Malden, C., Ratnayake, M. et al. Diagnosis and Management of Syphilis in Patients With HIV Co-infectionCurr Treat Options Infect Dis (2020). https://doi.org/10.1007/s40506-020-00225-6

Published

Purpose of review

Syphilis cases are on the increase especially in men who have sex with men (MSM) in urban areas of high-income countries.

There is a strong association between syphilis and HIV infections.

We review the more recent literature regarding the epidemiology, clinical manifestations, diagnostic investigations, treatment and follow-up of syphilis in HIV infection.

  • Read abstract here (For full text access you can purchase from the publisher or see your librarian)

Information about TRUVADA and ATRIPLA delisting

Australian Federation of AIDS Organisations (AFAO), March 30th 2020

From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS).

There are alternatives to Truvada for PrEP in Australia.

Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin Generic Health. The drugs manufactured by these three suppliers contain the same active ingredients as Truvada.

In addition, from October 2020 Atripla will be delisted. A generic equivalent of Atripla has been approved by the PBS for community members who wish to continue using Atripla.

We encourage you to talk to your prescribing doctor if you want more information about these changes.

For more information, visit the following websites: